| 11.64 0 (0%) | 06-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 17.52 |
1-year : | 20.46 |
| Resists | First : | 15 |
Second : | 17.52 |
| Pivot price | 13.19 |
|||
| Supports | First : | 12.92 |
Second : | 11.64 |
| MAs | MA(5) : | 13.18 |
MA(20) : | 13.25  |
| MA(100) : | 12.84 |
MA(250) : | 12.09 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 47.6 |
D(3) : | 50 |
| RSI | RSI(14): 57.2 |
|||
| 52-week | High : | 15.5 | Low : | 11.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TLGY ] has closed Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 12.76 - 12.82 | 12.82 - 12.88 |
| Low: | 12.6 - 12.67 | 12.67 - 12.73 |
| Close: | 12.64 - 12.75 | 12.75 - 12.85 |
TLGY Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on targets in biopharma or technology enabled business-to-consumer industries worldwide. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Fri, 30 May 2025
Saylor’s Contrarian Bet Morphs Into Crypto Gold Rush - Bloomberg.com
Wed, 09 Apr 2025
TLGY Acquisition Explores Partnership with Ethena Foundation - TipRanks
Wed, 20 Nov 2024
TLGY Stock Soars to All-Time High, Reaching $11.65 - Investing.com
Thu, 20 Jun 2024
TLGY Acquisition Corp. Undergoes Major Restructuring and Leadership Shake-Up - TipRanks
Wed, 08 May 2024
TLGY Acquisition Pushes Verde Deadline Back a Month - The SPAC Conference
Thu, 21 Mar 2024
Bioplastics player Verde Bioresins terminates SPAC deal - Packaging Dive
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 4 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 97.7 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.93 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -1.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | 86.87 |
| PEG Ratio | 0 |
| Price to Book value | -15.11 |
| Price to Sales | 0 |
| Price to Cash Flow | -32.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|